SOC Telemed, Inc.

Operating margin

−56.1%

Net margin

−53.5%

Return on equity

−30.2%

Return on assets

−18.4%

Return on capital (ROCE)

−20.7%

Liabilities / assets

39.1%

Debt / equity

0.64×

Book value / share

$2.18

Revenue growth (YoY)

62.8%

Net income growth (YoY)

—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Altman Z″ (distress)

-2.06distress

Accruals / assets

−3.8%clean

Beneish M-Score

-1.48elevated

Piotroski F-Score

4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

• Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventApr 6, 2022
• Shareholder voteApr 5, 2022
• Results of operationsMar 31, 2022
• Entered a material agreementFeb 4, 2022
• Other material eventFeb 3, 2022
• Director / officer changeDec 27, 2021
• Costs from exit or disposalNov 3, 2021
• Director / officer changeSep 15, 2021

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.